Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. According to the above diagnostic criteria, clearly diagnosed as patients with stable vitiligo; 2. all have more than 6 months of conventional treatment (oral, topical drugs or traditional phototherapy, etc.) is not effective; 3. Age 5-70 years old, men and women are not limited; 4. have not used corticosteroids, calcium-modulated neural phosphatase inhibitors and antioxidants and other topical drugs in the last 1 month; 5. No localized skin lesions or generalized skin have received any phototherapy, including PUVA, NB-UVB, etc. in the last 1 month; 6. All patients have good compliance and can be followed up as scheduled; 7. Agreed to videotape the skin lesions and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women, or the elderly and infirm who have difficulty in tolerating transplantation; 2. Those with keloid body, bleeding tendency, local or systemic infection; 3. Those with serious heart, liver, kidney, endocrine and other systemic diseases or suffering from immunodeficiency diseases and tumors; 4. Those who have been allergic to ultraviolet light in the past; 5. Those who have missed a visit or have had a serious adverse reaction during the course of treatment; 6. Other conditions that the investigator believes may be inappropriate for enrollment, such as the presence of increased risk to the subject or the presence of any condition that interferes with the results of the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complex color area; | — |
Secondary
| Measure | Time frame |
|---|---|
| The time when the obvious effect appears;Safety observation; | — |
Countries
China
Contacts
People's Hospital of Xinjiang Uygur Autonomous Region